Samuel Broderick

4.0k total citations
25 papers, 714 citations indexed

About

Samuel Broderick is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Samuel Broderick has authored 25 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Samuel Broderick's work include Cardiac Imaging and Diagnostics (10 papers), Acute Myocardial Infarction Research (8 papers) and Cardiovascular Function and Risk Factors (5 papers). Samuel Broderick is often cited by papers focused on Cardiac Imaging and Diagnostics (10 papers), Acute Myocardial Infarction Research (8 papers) and Cardiovascular Function and Risk Factors (5 papers). Samuel Broderick collaborates with scholars based in United States, United Kingdom and Canada. Samuel Broderick's co-authors include Linda K. Shaw, Jorge A. García, Christian Kollmannsberger, Walter M. Stadler, Ulka N. Vaishampayan, Susan Halabi, Christine M. Lusk, Andrew J. Armstrong, Tim Eisen and Robert E. Hawkins and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Samuel Broderick

24 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Broderick United States 14 319 285 275 177 135 25 714
Benjamin E. Haithcock United States 13 434 1.4× 143 0.5× 178 0.6× 103 0.6× 267 2.0× 48 842
Stefano Cafarotti Switzerland 14 285 0.9× 58 0.2× 72 0.3× 35 0.2× 197 1.5× 54 581
Yutian Lai China 14 424 1.3× 151 0.5× 66 0.2× 36 0.2× 259 1.9× 55 761
Jaime Escallón Canada 12 92 0.3× 42 0.1× 183 0.7× 183 1.0× 196 1.5× 29 586
Dana McGlothlin United States 12 429 1.3× 395 1.4× 235 0.9× 74 0.4× 115 0.9× 20 762
Tatsuya Tsuji Japan 15 230 0.7× 80 0.3× 135 0.5× 56 0.3× 398 2.9× 50 753
Juan Antonio Virizuela Spain 12 165 0.5× 35 0.1× 78 0.3× 78 0.4× 127 0.9× 57 587
Vesa Perhoniemi Finland 13 192 0.6× 56 0.2× 122 0.4× 64 0.4× 385 2.9× 27 654
Chad A. Reichard United States 15 493 1.5× 24 0.1× 112 0.4× 108 0.6× 114 0.8× 42 707
Yasunori Tsuboi Japan 11 138 0.4× 159 0.6× 71 0.3× 32 0.2× 58 0.4× 28 435

Countries citing papers authored by Samuel Broderick

Since Specialization
Citations

This map shows the geographic impact of Samuel Broderick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Broderick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Broderick more than expected).

Fields of papers citing papers by Samuel Broderick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Broderick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Broderick. The network helps show where Samuel Broderick may publish in the future.

Co-authorship network of co-authors of Samuel Broderick

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Broderick. A scholar is included among the top collaborators of Samuel Broderick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Broderick. Samuel Broderick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ludwig, Lisa, Scott N. Compton, Samuel Broderick, et al.. (2025). Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety. Journal of Child and Adolescent Psychopharmacology. 35(6). 326–336.
2.
Compton, Scott N., Samuel Broderick, John Orazem, et al.. (2023). Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES). Journal of Child and Adolescent Psychopharmacology. 33(1). 2–13. 5 indexed citations
3.
Compton, Scott N., Samuel Broderick, John Orazem, et al.. (2021). Sertraline Pediatric Registry for the Evaluation of Safety: Design and Clinical Characteristics of Pediatric Patients Prescribed Sertraline. Journal of Child and Adolescent Psychopharmacology. 31(6). 411–420. 3 indexed citations
4.
Ciccone, Emily J., Donaldson F. Conserve, Gaurav Dave, et al.. (2021). At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study. BMC Public Health. 21(1). 2209–2209. 13 indexed citations
5.
Broderick, Samuel, Karen Chiswell, Linda K. Shaw, et al.. (2017). Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). The American Journal of Cardiology. 119(11). 1703–1709. 4 indexed citations
7.
Broderick, Samuel, Linda K. Shaw, Karen Chiswell, et al.. (2017). Race and Sex Differences in QRS Interval and Associated Outcome Among Patients with Left Ventricular Systolic Dysfunction. Journal of the American Heart Association. 6(3). 12 indexed citations
8.
Armstrong, Andrew J., Susan Halabi, Tim Eisen, et al.. (2016). Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. The Lancet Oncology. 17(3). 378–388. 311 indexed citations
9.
Shen, Lan, John P. Vavalle, Samuel Broderick, Linda K. Shaw, & Pamela S. Douglas. (2016). Antianginal medications and long‐term outcomes after elective catheterization in patients with coronary artery disease. Clinical Cardiology. 39(12). 721–727. 6 indexed citations
10.
Mentz, Robert J., Samuel Broderick, Linda K. Shaw, et al.. (2014). Persistent Angina Pectoris in Ischaemic Cardiomyopathy: Increased Rehospitalization and Major Adverse Cardiac Events. European Journal of Heart Failure. 16(8). 854–860. 14 indexed citations
11.
Holmqvist, Fredrik, Samuel Broderick, Devinder Singh, et al.. (2014). Clinical outcome as a function of the PR-interval--there is virtue in moderation: data from the Duke Databank for cardiovascular disease. EP Europace. 17(6). 978–985. 19 indexed citations
12.
Mentz, Robert J., Samuel Broderick, Linda K. Shaw, Mona Fiuzat, & Christopher M. O’Connor. (2013). Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 63(3). 251–258. 29 indexed citations
13.
Mentz, Robert J., Samuel Broderick, Linda K. Shaw, Mona Fiuzat, & Christopher M. O’Connor. (2013). ASSOCIATION BETWEEN ANGINA AND OUTCOMES IN HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION: ANALYSIS FROM THE DUKE DATABANK FOR CARDIOVASCULAR DISEASE. Journal of the American College of Cardiology. 61(10). E682–E682. 1 indexed citations
14.
Domanski, Michaël, Kenneth W. Mahaffey, Sorin J. Brener, et al.. (2012). Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery. Survey of Anesthesiology. 56(1). 5–6. 44 indexed citations
15.
Hess, Connie N., Samuel Broderick, Jonathan P. Piccini, et al.. (2012). Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. American Heart Journal. 164(4). 607–615. 18 indexed citations
16.
Williams, Eric S., Kevin L. Thomas, Samuel Broderick, et al.. (2012). Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: Results from the Duke Databank for Cardiovascular Disease (DDCD). American Heart Journal. 164(3). 434–441. 42 indexed citations
17.
Angiolillo, Dominick J., Robert C. Welsh, Dietmar Trenk, et al.. (2012). Pharmacokinetic and Pharmacodynamic Effects of Elinogrel. Circulation Cardiovascular Interventions. 5(3). 347–356. 20 indexed citations
18.
Horwich, Tamara B., Samuel Broderick, Leway Chen, et al.. (2011). Relation Among Body Mass Index, Exercise Training, and Outcomes in Chronic Systolic Heart Failure. The American Journal of Cardiology. 108(12). 1754–1759. 42 indexed citations
19.
Cavender, Matthew A., Karen P. Alexander, Samuel Broderick, et al.. (2009). Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease. American Heart Journal. 158(6). 933–940. 24 indexed citations
20.
Melloni, Chiara, James Roach, Andrzej S. Kosinski, et al.. (2009). Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trial. American Heart Journal. 158(5). 726–733. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026